BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral activity of adenosine deaminase-resistant oxetanocin A derivatives: 2-halogeno-oxetanocin A. 1993

A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama

UI MeSH Term Description Entries
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D006846 Hydrocarbons, Halogenated Hydrocarbon compounds with one or more HYDROGEN atoms substituted with HALOGENS. Halogenated Hydrocarbons
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
A mini-review on synthesis and antiviral activity of natural product oxetanocin A derivatives.
October 2022, Bioorganic & medicinal chemistry,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Synthesis and antiviral activity of 3'-fluorocarbocyclic oxetanocin A.
January 1995, Chemical & pharmaceutical bulletin,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent.
April 1977, Journal of medicinal chemistry,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
The synthesis of 5-halogeno-2-thiouracil and 6-methyl-5-halogeno-2-thiouracil derivatives.
May 1948, Journal of the American Chemical Society,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles.
January 1994, Journal of medicinal chemistry,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Synthesis and antiviral activities of carbocyclic oxetanocin analogues.
October 1990, Chemical & pharmaceutical bulletin,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Increased adenosine deaminase synthesis and messenger RNA activity in deoxycoformycin-resistant cells.
January 1983, The Journal of biological chemistry,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Synthesis, antiprotozoal and antibacterial activity of nitro- and halogeno-substituted benzimidazole derivatives.
January 2002, Acta biochimica Polonica,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
Total adenosine deaminase highly correlated with adenosine deaminase 2 activity in serum.
February 2022, Annals of the rheumatic diseases,
A Masuda, and M Kitagawa, and A Tanaka, and S Saito, and N Shimada, and R Ikeda, and H Hoshino, and T Daikoku, and Y Nishiyama
[Antiviral activity of benzimidazole derivatives. I. Synthesis and antiviral activity of hydroxyalkylbenzimidazole derivatives].
June 1968, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!